Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnerships 600x60px

News > All

Please find below news from the United Kingdom (Great Britain) and the Republic of Ireland as well as about organisations from these countries.

Total search results: 4230 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 15 16 17 ... 41 42 43  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Meda AB. (2/10/16). "Press Release: Year-end Report, January–December 2015". 2016-02-10
Meda AB. (2/10/16). "Press Release: Statement by the Board of Directors of Meda in Relation to the Public Offer by Mylan. The Board of Directors of Meda Unanimously Recommends that the Shareholders of Meda Accept the Offer Made by Mylan". 2016-02-10
4D Pharma plc. (2/10/16). "Press Release: Acquisition [of Tucana Health Ltd.]". 2016-02-10
Adaptimmune Therapeutics plc. (2/9/16). "Press Release: U.S. Food and Drug Administration Grants Breakthrough Therapy Designation for Adaptimmune’s Affinity Enhanced T-cell Therapy Targeting NY-ESO in Synovial Sarcoma". Philadeliphia, PA & Oxford. 2016-02-09
Genomics England Ltd.. (2/9/16). "Press Release: Genomics England Selects Icon as Data Management Partner". 2016-02-09
Imperial Innovations Group plc. (2/4/16). "Press Release: Result of Placing [Not for United States, Australia, Canada or Japan or any other jurisdiction in which unlawful] ". 2016-02-04
Curetis N.V.. (2/3/16). "Press Release: Curetis Expands Commercial Team. Company Hires Willem Haagmans as Head of Sales EMEA". Amsterdam & Holzgerlingen. 2016-02-03
Medicxi Ventures. (2/3/16). "Press Release: Medicxi Ventures, Formerly Index Ventures Life Sciences, Launches as an Independent Venture Capital Firm and Announces Closing of a €210m Fund including GSK and Johnson & Johnson Innovation". Castres. 2016-02-03
SBRI Healthcare. (2/3/16). "Press Release: £4.4 Million Awarded in Latest SBRI Healthcare Competition". 2016-02-03
EKF Diagnostics Holdings plc. (2/3/16). "Press Release: Trading Update". 2016-02-03
Adaptimmune Therapeutics plc. (2/3/16). "Press Release: Adaptimmune to Participate in Two Upcoming Investor Conferences". Philadeliphia, PA & Oxford. 2016-02-03
AstraZeneca plc. (2/3/16). "Press Release: Tagrisso (osimertinib) Approved in EU as First-in-class Treatment for Patients with EGFR T790M Mutation-positive Metastatic Non-small Cell Lung Cancer". 2016-02-03
Adaptimmune Therapeutics plc. (2/2/16). "Press Release: Adaptimmune and GSK Expand Strategic Immunotherapy Collaboration". London, Philadelphia, PA & Oxford. 2016-02-02
Cell and Gene Therapy Catapult, The. (2/2/16). "Press Release: Cell Therapy Catapult Is Now the Cell and Gene Therapy Catapult. New Name Reflects Mandate of the Catapult to Serve the Industry". London. 2016-02-02
Mission Therapeutics Ltd.. (2/2/16). "Press Release: Mission Therapeutics Raises £60 Million to Progress Development of Novel DUB Inhibitors from Innovative Drug Platform". Cambridge. 2016-02-02
Kymab Ltd.. (2/2/16). "Press Release: Kymab Succeeds in Revoking Regeneron’s UK VelocImmune Patents". Cambridge. 2016-02-02
Abbott Laboratories Inc.. (2/1/16). "Press Release: Abbott to Acquire Alere, Becoming Leader in Point of Care Testing and Significantly Advancing Global Diagnostics Presence". Abbott Park, IL & Waltham, MA. 2016-02-01
Sartorius AG. (2/1/16). "Press Release: Sartorius Grows by Double Digits in Sales and Profit in 2015 – Positive Outlook for 2016 – Targets for 2020 Updated". Göttingen. 2016-02-01
Oxford Immunotec Global plc. (2/1/16). "Press Release: Patrick J. Balthrop, Sr., Former CEO of Luminex, Joins Oxford Immunotec Board of Directors". Oxford & Marlborough, MA. 2016-02-01
Francis Crick Institute Ltd., The. (2/1/16). "Press Release: HFEA Approval for New »Gene Editing« Techniques". 2016-02-01
Oxford BioMedica plc. (1/29/16). "Press Release: Oxford BioMedica Announces Initiation of Second CART Programme for Major Pharmaceutical Company". Oxford. 2016-01-29
Agilent Technologies Inc.. (1/27/16). "Press Release: Agilent Technologies Wins Award for Innovation in Liquid Chromatography. Dual-Needle Technology Enhances Speed, Flexibility". Santa Clara, CA. 2016-01-27
Cancer Research UK. (1/27/16). "Press Release: CRT Announces License Agreement with MSD to Develop Inhibitors of PRMT5 for Cancer and Blood Disorders". 2016-01-27
Genticel S.A.. (1/27/16). "Press Release: Genticel Reports Initial Results at 12 Months from Phase 2 Trial of HPV Immunoterapeutic Candidate, GTL0001". Paris & Toulouse. 2016-01-27
Inivata Ltd.. (1/26/16). "Press Release: Inivata Completes £31.5 Million ($45M) Series A Fundraising Round". Cambridge. 2016-01-26
Pharnext S.A.S.. (1/26/16). "Press Release: Pharnext Collaborates with OrphanDev in Europe for Its Phase 3 Clinical Trial PLEO-CMT in Charcot-Marie Tooth Type 1A Disease (CMT 1A)". Paris. 2016-01-26
Immunocore Ltd.. (1/25/16). "Press Release: Immunocore’s IMCgp100 Granted Orphan Drug Designation by US FDA for the Treatment of Uveal Melanoma". 2016-01-25
Apollo Therapeutics Fund. (1/25/16). "Press Release: Apollo Therapeutics. Consortium of World-Leading UK Universities and Global Pharmaceutical Companies Launch £40 Million Fund to Drive Therapeutic Innovation". London. 2016-01-25
Domainex Ltd.. (1/25/16). "Press Release: Domainex and Cresset Announce Drug Discovery Services Alliance". Cambridge. 2016-01-25
Vasopharm GmbH. (1/21/16). "Press Release: Vasopharm Announces EUR 20 Million Fundraising to Progress Treatment for Traumatic Brain Injury". Würzburg. 2016-01-21
Protagen AG. (1/21/16). "Press Release: Protagen AG Joins RA-MAP Consortium to Support Identification of Predictors of Remission in Rheumatoid Arthritis (RA)". 2016-01-21
Abingworth LLP. (1/21/16). "Press Release: Abingworth Raises $105m for First Dedicated Clinical Co-Development Fund". 2016-01-21
Mucosis B.V.. (1/20/16). "Press Release: Mucosis Secures €3.7M from Wellcome Trust to Fund Clinical Trials of its Respiratory Syncytial Virus Vaccine in Partnership with Imperial College London". Groningen. 2016-01-20
Novozymes A/S. (1/19/16). "Press Release: Novozymes Separates Its Biopharma Activities to Form Independent Company". 2016-01-19
Blue Scientific Ltd.. (1/15/16). "Press Release: Blue Scientific Now Exclusive Distributor for Ametek in Ireland". 2016-01-15
Swedish Orphan Biovitrum AB. (1/14/16). "Press Release: Chief Medical Officer Birgitte Volck to Leave Sobi". 2016-01-14
Microsaic Systems plc. (1/14/16). "Press Release: Grant of Share Options". 2016-01-14
Merck & Co., Inc.. (1/11/16). "Press Release: Merck Acquires IOmet Pharma and Expands Immuno-Oncology Development Program". Kenilworth, NJ. 2016-01-11
Shire plc. (1/11/16). "Press Release: Shire to Combine with Baxalta, Creating the Global Leader in Rare Diseases". Dublin & Bannockburn, IL. 2016-01-11
Nordic Nanovector ASA. (1/8/16). "Press Release: Nordic Nanovector to Present at the 8th Annual Biotech Showcase Conference in San Francisco". Oslo. 2016-01-08
Glycotope GmbH. (1/7/16). "Press Release: Glycotope Names Paul G Higham as New Chief Executive Officer". Berlin. 2016-01-07
Kymab Ltd.. (1/7/16). "Press Release: Kymab and MD Anderson Announce Strategic Partnership in Immuno-Oncology Research & Development". Cambridge & Houston, TX. 2016-01-07
Eurofins Scientific. (1/7/16). "Press Release: Eurofins Genomics and Weatherbys Ireland Join Forces to Genotype One Million Cattle". 2016-01-07
Irvine Scientific. (1/7/16). "Press Release: Irvine Scientific Acquires Leading Distributor in European IVF Market BioCare Europe S.r.l.". Santa Ana, CA & Rome. 2016-01-07
PsiOxus Therapeutics Ltd.. (1/7/16). "Press Release: PsiOxus Therapeutics Appoints Dr Paolo Paoletti as Chairman of the Board. Former President of GSK Oncology Adds Depth of Cancer R&D Leadership". Oxford. 2016-01-07
Illumina, Inc.. (1/7/16). "Press Release: Illumina Files Two Patent Infringement Suits in Europe for Infringement of Patents for NIPT". San Diego, CA. 2016-01-07
Waters Corporation. (1/6/16). "Press Release: Waters and BioCity to Establish an Open Access Analytical Laboratory in the BioHub at Alderley Park, UK". Milford, MA. 2016-01-06
Innate Pharma S.A.. (1/5/16). "Press Release: Upcoming Investor Conferences". 2016-01-05
Genticel S.A.. (1/5/16). "Press Release: Genticel Appoints Rémi Palmantier, PhD, as Chief Scientific Officer to Accelerate Its Development". Paris & Toulouse. 2016-01-05
Genomics plc. (1/4/16). "Press Release: Genomics and Vertex Collaborate to Identify Target Therapeutic Pathways". Oxford. 2016-01-04
Cellectis S.A.. (12/23/15). "Press Release: Cellectis Files First Clinical Trial Application for UCART19, an Allogeneic Gene Edited CAR T-Cell Product for Hematological Malignancies". New York. 2015-12-23
Waters Corporation. (12/22/15). "Press Release: Waters Products Named Top Innovations for 2015". Milford, MA. 2015-12-22
Effector Therapeutics, Inc.. (12/22/15). "Press Release: Effector Therapeutics Raises $40 Million Series B Financing". San Diego, CA. 2015-12-22
Bayer AG. (12/21/15). "Press Release: Bayer and CRISPR Therapeutics AG Join Forces to Discover, Develop and Commercialize Potential Cures for Serious Genetic Diseases". Leverkusen & Basel. 2015-12-21
Microsaic Systems plc. (12/21/15). "Press Release: Directorate Changes". 2015-12-21
Oxford Immunotec Global plc. (12/18/15). "Press Release: Oxford Immunotec to Present at the 34th Annual J.P. Morgan Healthcare Conference". Oxford & Marlborough, MA. 2015-12-18
Uniqure N.V.. (12/18/15). "Press Release: Uniqure Appoints Dan Soland as Chief Executive Officer". Amsterdam. 2015-12-18
AstraZeneca plc. (12/17/15). "Press Release: AstraZeneca Enhances Long-term Growth through Oncology Investment in Acerta Pharma". 2015-12-17
AstraZeneca plc. (12/17/15). "Press Release: AstraZeneca Completes Acquisition of ZS Pharma". 2015-12-17
Ergomed plc. (12/16/15). "Press Release: Ergomed plc Provides Update on Co-Development Partnerships". Guildford. 2015-12-16
Malin Corporation plc. (12/16/15). "Press Release: Malin Announces Investment in Gene Therapy Company Poseida Therapeutics, Inc.". Dublin. 2015-12-16
AstraZeneca plc. (12/16/15). "Press Release: AstraZeneca to Strengthen Therapy Area Franchise through Acquisition of Takeda’s Respiratory Business". 2015-12-16
AstraZeneca plc. (12/16/15). "Press Release: AstraZeneca Continues Strategic Investment in China to Accelerate Delivery of Innovative Biologics and Targeted Medicines". 2015-12-16
Sophia Genetics S.A.. (12/16/15). "Press Release: Marc Coucke Leads Series C Round in Sophia Genetics". Lausanne. 2015-12-16
Genomics England Ltd.. (12/16/15). "Press Release: New NHS Centres Join 100,000 Genomes Project". 2015-12-16
AstraZeneca plc. (12/15/15). "Press Release: AstraZeneca Completes Agreement with Perrigo for Rights to Entocort in the US". 2015-12-15
Shire plc. (12/15/15). "Press Release: Shire to Present at 34th Annual J.P. Morgan Healthcare Conference". Lexington, MA. 2015-12-15
AstraZeneca plc. (12/14/15). "Press Release: Discussions with Acerta Pharma BV". 2015-12-14
Premaitha Health plc. (12/14/15). "Press Release: Premaitha Health Signs Investment Agreement with Thermo Fisher Scientific". Manchester. 2015-12-14
AstraZeneca plc. (12/11/15). "Press Release: AstraZeneca to Harness Power of the Secretome and Develop Next-generation Biologics in Collaboration with New Wallenberg Centre for Protein Research". 2015-12-11
Blue Scientific Ltd.. (12/11/15). "Press Release: Parallel Imaging MS/MS Installed at Maastricht University M4I". 2015-12-11
Eurofins Scientific. (12/10/15). "Press Release: Eurofins Decides Not to Proceed with the Placement Offer for New Shares Due to Poor Global Market Conditions [Not for US, CA, AU or JP]". 2015-12-10
Freeline Therapeutics Ltd.. (12/10/15). "Press Release: Syncona and UCLB Launch Freeline Therapeutics to Develop Gene Therapies for Bleeding Disorders". London. 2015-12-10
[iito] Business Intelligence. (12/9/15). "Press Release: Launches Today. New Business Web Portal for the UK and Irish Life Sciences Targets Decision Makers World-wide". Bremen & London. 2015-12-09
Illumina, Inc.. (12/9/15). "Press Release: Desktop Genetics Receives Strategic Investment from Illumina to Advance Genome Editing Software Platform". London & San Diego, CA. 2015-12-09
Eurofins Scientific. (12/9/15). "Press Release: Eurofins Announces the Launch of the Placement of approximately 1 Million New Ordinary Shares by Way of an Accelerated Book Building Offering to Institutional Investors [Not for US, CA, AU or JP]". 2015-12-09
Sofinnova Partners. (12/8/15). "Press Release: Sofinnova Partners Raises €300 Million Healthcare Fund". Paris. 2015-12-08
4D Pharma plc. (12/8/15). "Press Release: Placing to Raise £30 Million by the Issue of 3,797,469 New Ordinary Shares at 790p per Share". 2015-12-08
Key Organics Ltd.. (12/7/15). "Press Release: New Bionet 2nd Generation Premium Fragment Library". 2015-12-07
Cypralis Ltd.. (12/7/15). "Press Release: Cypralis Limited Announces Collaboration with Johnson & Johnson Innovation in the Field of Neurodegenerative Diseases". Ongar. 2015-12-07
Porvair plc. (12/7/15). "Press Release: Pre-close Trading Update and Acquisition". 2015-12-07
Servier. (12/7/15). "Press Release: Servier Announces Expansion of Collaboration for the Development and Commercialization of Anticancer Drug Candidates Targeting Apoptosis". Suresnes. 2015-12-07
Auspherix Ltd.. (12/5/15). "Press Release: Auspherix Appoints Dr. Neil Miller as Chief Scientific Officer". Cambridge & Stevenage. 2015-12-05
DNA Electronics Ltd.. (12/4/15). "Press Release: DNAe Expands US Operations with Clinical Diagnostic Development and Manufacturing Site in San Diego". London & Albuquerque, NM. 2015-12-04
Zymeworks Inc.. (12/3/15). "Press Release: Zymeworks Announces Antibody Fc Engineering Collaboration and License Agreement with GSK". Vancouver. 2015-12-03
Oxford Immunotec Global plc. (12/3/15). "Press Release: Oxford Immunotec Announces Availability of the T-SPOT.PRT Test in the United States". Oxford & Marlborough, MA. 2015-12-03
Kesios Therapeutics Ltd.. (12/2/15). "Press Release: Kesios Therapeutics Raises £19 Million in Series A Financing. Builds Management Team Led by Dr. Paolo Paoletti as CEO". London. 2015-12-02
Microsaic Systems plc. (12/2/15). "Press Release: Trading Update and Directorate Changes". 2015-12-02
Adaptimmune Therapeutics plc. (12/1/15). "Press Release: Adaptimmune and Universal Cells Announce Collaboration to Develop Allogeneic T-Cell Therapies". Philadeliphia, PA & Oxford. 2015-12-01
Protagen AG. (12/1/15). "Press Release: Protagen AG Joins MATURA Consortium to Support Identification of Treatment Response Predictors in Rheumatoid Arthritis (RA)". 2015-12-01
MedDay Pharmaceuticals S.A.S.. (12/1/15). "Press Release: MedDay Provides Update on MS-ON Study of MD-1003". Paris. 2015-12-01
Titian Software Ltd.. (12/1/15). "Press Release: Titian Focuses on Bringing Sample Management Solutions to Any Size of Organisation with New Appointments and Options". London. 2015-12-01
Heptares Therapeutics Ltd.. (11/30/15). "Press Release: Heptares Enters Strategic Drug Discovery Collaboration with Pfizer Inc. Focused on GPCR Targets Across Multiple Therapeutic Areas". London & Boston, MA. 2015-11-30
Human Longevity, Inc.. (11/30/15). "Press Release: Human Longevity, Inc. (HLI) Acquires Cypher Genomics, Inc. – Cypher CEO, Ashley Van Zeeland, Ph.D. to Become Head of HLI’s Pediatric Business". San Diego, CA. 2015-11-30
Pelago Bioscience AB. (11/27/15). "Press Release: Pelago Bioscience AB and AstraZeneca Enters into Research Collaboration and License Agreement on the CETSA Method". Stockholm & Cambridge. 2015-11-27
Sophia Genetics S.A.. (11/26/15). "Press Release: Sophia Genetics Reaches Milestone to Become the Global Leader in Precision Medicine, Connecting over 100 hospitals and Laboratories to Form the World’s Largest Clinical Genomics Community for Molecular Di 2015-11-26
Biopta Ltd.. (11/25/15). "Press Release: ReproCell Acquires Biopta to Expand Its Drug Discovery Services". Glasgow. 2015-11-25
GlaxoSmithKline plc. (11/25/15). "Press Release: GSK Announces Start of Phase III Study of Sirukumab in Giant Cell Arteritis". London. 2015-11-25
Horizon Discovery Group plc. (11/25/15). "Press Release: Horizon Discovery Group plc Signs Three Diagnostic Agreements Worth an Initial $3.3 Million". Cambridge. 2015-11-25
Heptares Therapeutics Ltd.. (11/25/15). "Press Release: Teva and Heptares Enter Agreement to Discover and Develop Novel, Small-molecule CGRP Antagonists for Treatment of Migraine". Jerusalem & London. 2015-11-25
next pagenext page 1 2 3 ... 15 16 17 ... 41 42 43  next pagenext page


Picture EBD Group Bio-Europe 2018 Copenhagen Denmark November 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture BioM Forum Translational Medicine 2018 Würzburg Germany 600x60px

» top